marijuana stocks news

OrganiGram Holdings Inc. (OGRMF)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Nov 30, 2014 Jul 31, 2014 Apr 30, 2014 Jan 31, 2014
Total Revenue 12   –   –   –  
Cost of Revenue 6 – – –
Gross Profit 6   –   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 723 177 24 12
Non Recurring – – 2 (11)
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (718) (177) (26) (2)
Income from Continuing Operations
Total Other Income/Expenses Net – 5 – –
Earnings Before Interest And Taxes (718) (172) (25) (2)
Interest Expense – – – –
Income Before Tax (718) (172) (25) (2)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (718) (172) (25) (2)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (718) (172) (25) (2)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (718) (172) (25) (2)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Ascend Wellness Holdings, Inc. (AAWH) to Hold Third Quarter 2024 Earnings Conference Call on Tuesday November 12, 2024

AWH to Hold Third Quarter 2024 Earnings Conference Call on Tuesday November…

$GWPH Initiates First Phase 3 Pivotal Trial for Epidiolex

GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial for Epidiolex in Dravet…

Cresco Labs (CRLBF) Reaches 60 Nationwide Dispensaries with the Opening of Two Florida Stores

Cresco Labs Reaches 60 Nationwide Dispensaries with the Opening of Two Florida…

Cara Therapeutics, Inc. (CARA) Appoints Christopher A. Posner to Board of Directors

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors Cara Therapeutics,…